M
IMEPro
I11.9 Internal Medicine
Updated March 2026

Hypertensive heart disease without heart failure

ICD-10 Code: I11.9 · Body Part: Head/Brain (TBI)

QME Evaluation Process

Echocardiogram for LVH, stress testing, functional assessment. Chapter 3 cardiovascular impairment. Evaluate work-related stress contribution.

Typical Impairment Rating

10-35% WPI

AMA Guides Edition

5th Edition

Common Treatments

+ Antihypertensive medication
+ Cardiac monitoring
+ Lifestyle modification

Related Conditions

Body Part Guide

Head/Brain (TBI) Evaluation Guide

Impairment rating methods, common conditions, and QME evaluation protocols

View Guide →

QME Specialties for Hypertensive heart disease without heart failure

Find a QME Specialist

Browse QME-certified physicians who evaluate hypertensive heart disease without heart failure and related head/brain (tbi) conditions in California.

Browse Neurology Physicians →

Frequently Asked Questions

What is Hypertensive heart disease without heart failure (I11.9)?

Hypertensive heart disease without heart failure is an ICD-10 diagnosis code (I11.9) classified under Internal Medicine conditions. It affects the Head/Brain (TBI) and is commonly encountered in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.

How is I11.9 rated for impairment?

The typical whole person impairment (WPI) range for Hypertensive heart disease without heart failure is 10-35% WPI. The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.

What is the QME evaluation process for I11.9?

Echocardiogram for LVH, stress testing, functional assessment. Chapter 3 cardiovascular impairment. Evaluate work-related stress contribution.

What treatments are common for Hypertensive heart disease without heart failure?

Common treatments for Hypertensive heart disease without heart failure include Antihypertensive medication, Cardiac monitoring, Lifestyle modification. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.